University of Arizona Cancer Center researcher Dr. Daniel Persky led a study that found many patients with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma (DLBCL), can safely skip radiation and receive fewer chemotherapy treatments.
On Oct. 12, the university hopes to resume in-person instruction for classes of 30 or fewer students that were designated in-person or flex in-person courses at the time of registration.
The new faculty cardiologists, Drs. Keng Pineda and Andrew Williams, bring expertise in interventional cardiology, cardiac imaging, cardio-oncology and sports cardiology to the University of Arizona Health Sciences and Banner – University Medicine Tucson.
As more older adults use smartphones, College of Pharmacy researcher Dr. Jeannie Lee hopes to improve medication adherence and blood pressure rates with a management system in the palm of their hand.
Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. Researchers took a closer look at antibody production to figure out why.
Research shows SARS-CoV-2 promotes pain relief through the receptor neuropilin-1, which gives scientists a new target for non-opioid pain therapeutics and offers one possible explanation for the unrelenting spread of COVID-19.
A new study finds menopause-induced changes to protective immune cells may add to a spike in high blood pressure in postmenopausal women – findings with implications for sex differences in COVID-19 responses.
The number of positive test results on campus decreased following a 14-day shelter-in-place recommendation.
A $2.2 million federal grant will allow Dr. Eugene Chang, a sinus surgeon at the UArizona College of Medicine - Tucson, to investigate human genetic viral interactions in the development of sinus disease.
Sixteen first-year students are among 32 new PCP Scholarship recipients this academic year at the UArizona Colleges of Medicine in Tucson and Phoenix – both schools still have scholarships available.
University of Arizona Health Sciences passes $200 million milestone in research funding in fiscal year 2020, addressing some of the world’s most challenging health conditions, including COVID-19.
While the campus has seen a spike in cases over the last few weeks, Friday’s positivity rate was down from last week, and no new students were admitted to isolation housing over the weekend.
Funded by the National Institutes of Health, the All of Us Research Program is a historic effort to collect and study data from at least 1 million people in the United States.
The Addiction Medicine Fellowship program at the University of Arizona College of Medicine – Tucson will use a $1.4 million federal grant to increase its training capacity, help combat Arizona’s opioid epidemic and increase services to rural and underserved communities across the state.
Dr. Meredith Hay won a $5.7 million grant for clinical trials on a novel peptide therapy that, if successful, would be the first drug to treat vascular dementia – the second most common form of dementia.
UArizona President Dr. Robert C. Robbins said the university expected to see an increase in COVID-19 cases, but it has become too much, necessitating a shelter-in-place recommendation similar to what the state faced in the spring.
Joining the University of Arizona Health Sciences in October, Dr. Geoffrey Rubin holds six U.S. patents for medical image analysis and is past chairman of radiology at Duke University School of Medicine.
Efforts to keep patients safe in the time of COVID-19 led to significant savings and innovation in chemotherapy delivery and earned University of Arizona Health Sciences center national recognition.
A study by University of Arizona Health Sciences researchers found that green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and number of days per month people experienced migraine headaches.
Dr. Theresa Dr. Cullen, director of the Pima County Health Department, said the county, university and other partners are working together on a “layered approach” to COVID-19 mitigation.